Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Laboratory diagnosis of Bartonella infections.
Agan BK, Dolan MJ. Agan BK, et al. Among authors: dolan mj. Clin Lab Med. 2002 Dec;22(4):937-62. doi: 10.1016/s0272-2712(02)00017-3. Clin Lab Med. 2002. PMID: 12489289 Review.
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK. Dolan MJ, et al. Nat Immunol. 2007 Dec;8(12):1324-36. doi: 10.1038/ni1521. Epub 2007 Oct 21. Nat Immunol. 2007. PMID: 17952079
Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy.
Kulkarni H, Okulicz JF, Grandits G, Crum-Cianflone NF, Landrum ML, Hale B, Wortmann G, Tramont E, Polis M, Dolan M, Lifson AR, Agan BK, Ahuja SK, Marconi VC. Kulkarni H, et al. J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):387-95. doi: 10.1097/QAI.0b013e3182219113. J Acquir Immune Defic Syndr. 2011. PMID: 21546844 Free PMC article.
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK. Gonzalez E, et al. Among authors: dolan mj. Science. 2005 Mar 4;307(5714):1434-40. doi: 10.1126/science.1101160. Epub 2005 Jan 6. Science. 2005. PMID: 15637236
HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK. Catano G, et al. Among authors: dolan mj. PLoS One. 2008;3(11):e3636. doi: 10.1371/journal.pone.0003636. Epub 2008 Nov 4. PLoS One. 2008. PMID: 18982067 Free PMC article.
Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.
Landrum ML, Hullsiek KH, Ganesan A, Weintrob AC, Crum-Cianflone NF, Barthel RV, O'Connell RJ, Fieberg A, Chun HM, Marconi VC, Dolan MJ, Agan BK; Infectious Disease Clinical Research Program HIV Working Group. Landrum ML, et al. Among authors: dolan mj. AIDS. 2010 Feb 20;24(4):545-55. doi: 10.1097/QAD.0b013e32832cd99e. AIDS. 2010. PMID: 19487908 Free PMC article.
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.
Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, Hale B, Crum-Cianflone N, Delmar J, Barthel V, Quinnan G, Agan BK, Dolan MJ; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group. Okulicz JF, et al. Among authors: dolan mj. J Infect Dis. 2009 Dec 1;200(11):1714-23. doi: 10.1086/646609. J Infect Dis. 2009. PMID: 19852669
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.
Okulicz JF, Le TD, Agan BK, Camargo JF, Landrum ML, Wright E, Dolan MJ, Ganesan A, Ferguson TM, Smith DM, Richman DD, Little SJ, Clark RA, He W, Ahuja SK. Okulicz JF, et al. Among authors: dolan mj. JAMA Intern Med. 2015 Jan;175(1):88-99. doi: 10.1001/jamainternmed.2014.4010. JAMA Intern Med. 2015. PMID: 25419650 Free PMC article.
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ. Ahuja SK, et al. Among authors: dolan mj. Nat Med. 2008 Apr;14(4):413-20. doi: 10.1038/nm1741. Epub 2008 Mar 30. Nat Med. 2008. PMID: 18376407 Free PMC article.
132 results